Last Updated on May 16, 2024
06sth May 2024, Michigan, USA – Revive Research Institute, Inc. has raised a new benchmark in clinical research and proudly announces its attainment of the prestigious GCSA Global Quality Standard for Clinical Research certification.
This remarkable accomplishment affirms the institute’s unwavering pursuit of excellence and solidifies its reputation as a pioneer in the clinical research industry.
By attaining this prestigious endorsement, the Revive reinforces its position as a trusted front-runner in clinical trials. The certification highlights Revive’s commitment to maintaining high standards of quality and integrity across all parts of its clinical research operations.
”Mazhar Jaffry, CEO & President expresses pride in this honorable moment of receiving GCSA certification, stating, "Our team at Revive Research Institute is pleased to have achieved this GCSA certification of Global Quality Standard for Clinical Research. This accomplishment is evidence of our unremitting pursuit of brilliance and our persistent adherence to best practices in clinical research."
Revive Research Institute exhibits a dedication to strict quality standards, safety for patients and ethical practices that are distinct and recognized by the GCSA Global Quality Standard for Clinical Research, which is an honor. Accomplishment of this standard reflects Revive Research Institute’s unwavering dedication to upholding the highest quality standards and ethics across all facets of clinical research operations.
About Revive Research Institute, Inc.
Revive Research Institute, located in Michigan USA, is steadfast in pioneering therapeutic progressions via clinical trials in several therapeutic areas. Our primary goal revolves around executing successful clinical trials for a range of pharmaceuticals and clinical research entities.
For further information or inquiries:
